Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative medications function by mimicking the natural actions of GLP-1, a hormone produced by the gut in response to consumption. By activating GLP-1 receptors in the pancreas, these compounds enhance insulin release and inhibit g

The management of diabetes is with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are glp-3 gaining significant attention. These medications offer promising mechanisms for controlling blood sugar levels and may improve the lives of individuals living with diabetes. This novel clas